Stephen Read wrote: > As Cycorp is the best funded company among those organizations with AGI as > their primary goal, I would state that for us enrichment is not the > motive.
Steve, I accept this as an honest statement of your personal motivations. However, I'm not sure that Cycorp's investors would endorse such a statement, would they? I'm sure they would prefer to endorse a statement such as "Cycorp's mission is to make a healthy profit via powerful AI technology." If given the choice between more profits and better AI, I am betting they would choose the former.... In the best of scenarios, profitability and scientific progress go hand in hand; but there are times in the history of almost any technology company when the two conflict as well. Having been on both the tech and biz sides of technology firms, I am aware of the difficulty of juggling one's responsibility to science with one's responsibility to shareholders. I'm not trying to say anything negative about Cycorp here -- I have the same issue with my own business pursuits, e.g. Biomind LLC, the company we've set up to pursue bioinformatics applications of Novamente technology. The Biomind investors love AGI and Novamente, but they also expect Biomind to provide a significant ROI. And building AGI while making money along the way is certainly a harder problem than building AGI -- which is a rather hard problem in itself!! -- Ben G ------- To unsubscribe, change your address, or temporarily deactivate your subscription, please go to http://v2.listbox.com/member/?[EMAIL PROTECTED]
